γ-Secretase-dependent cleavage of E-cadherin by staurosporine in breast cancer cells

Cell Communication and Adhesion

Volumn 19, Issue 1, 2012, Pages 11-16

  Yoo, Chul Bae ^a   Yun, Sang Moon ^a   Jo, Chulman ^a   Koh, Young Ho ^a  

^a Korea National Institute of Health   (South Korea)

Author keywords

secretase; Apoptosis; Breast cancer; Caspase; E cadherin

Indexed keywords

CASPASE 2; CASPASE 8; CASPASE INHIBITOR; GAMMA SECRETASE; GAMMA SECRETASE INHIBITOR; STAUROSPORINE; UNCLASSIFIED DRUG; UVOMORULIN; ZVAD FMK;

APOPTOSIS; ARTICLE; BREAST CANCER; CANCER CELL; CELL CONTACT; CELL SURFACE; CONTROLLED STUDY; CYTOSOL; DRUG CYTOTOXICITY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; PRIORITY JOURNAL; PROTEIN CLEAVAGE;

AMINO ACID CHLOROMETHYL KETONES; AMYLOID PRECURSOR PROTEIN SECRETASES; APOPTOSIS; BREAST NEOPLASMS; CADHERINS; CASPASE 2; CASPASE 8; CELL LINE, TUMOR; ENZYME INHIBITORS; FEMALE; HUMANS; MICROSCOPY, FLUORESCENCE; STAUROSPORINE;

EID: 84858841357     PISSN: 15419061     EISSN: 15435180     Source Type: Journal    
DOI: 10.3109/15419061.2012.665969     Document Type: Article

References (15)

1. Chae SS, Yoo CB, Jo C, Yun SM, Jo SA, Koh YH (2010). Caspases-2 and-8 are involved in the presenilin1/gamma-secretase-dependent cleavage of amyloid precursor protein after the induction of apoptosis. J Neurosci Res. 88: 1926-1933.
2. Gouaze V, Andrieu-Abadie N, Cuvillier O, Malagarie-Cazenave S, Frisach MF, Mirault ME, Levade T (2002). Glutathione peroxidase-1 protects from CD95-induced apoptosis. J Biol Chem. 277: 42867-42874. (Pubitemid 35285663)
3. Janicke RU, Ng P, Sprengart ML, Porter AG (1998). Caspase-3 is required for alpha-fodrin cleavage but dispensable for cleavage of other death substrates in apoptosis. J Biol Chem. 273: 15540-15545. (Pubitemid 28298165)
4. Keller SH, Nigam SK (2003). Biochemical processing of E-cadherin under cellular stress. Biochem Biophys Res Commun. 307: 215-223. (Pubitemid 36818856)
5. Muzio M, Chinnaiyan AM, Kischkel FC, O'Rourke K, Shevchenko A, Ni J, Scaffidi C, Bretz JD, Zhang M, Gentz R (1996). FLICE, a novel FADD-homologous ICE/CED-3-like protease, is recruited to the CD95 (Fas/APO-1) death-inducing signaling complex. Cell. 85: 817-827. (Pubitemid 26193033)
6. Nollet F, Berx G, van Roy F (1999). The role of the E-cadherin/catenin adhesion complex in the development and progression of cancer. Mol Cell Biol Res Commun. 2: 77-85. (Pubitemid 129532310)
7. Park CS, Kim OS, Yun SM, Jo SA, Jo I, Koh YH (2008). Presenilin 1/gamma-secretase is associated with cadmium-induced E-cadherin cleavage and COX-2 gene expression in T47D breast cancer cells. Toxicol Sci. 106: 413-422.
8. Ruegg UT, Burgess GM (1989). Staurosporine, K-252 and UCN-01: potent but nonspecific inhibitors of protein kinases. Trends Pharmacol Sci. 10: 218-220. (Pubitemid 19146392)
9. Seleznev K, Zhao C, Zhang XH, Song K, Ma ZA (2006). Calcium-independent phospholipase A2 localizes in and protects mitochondria during apoptotic induction by staurosporine. J Biol Chem. 281: 22275-22288. (Pubitemid 44181930)
10. Steinhusen U, Weiske J, Badock V, Tauber R, Bommert K, Huber O (2001). Cleavage and shedding of E-cadherin after induction of apoptosis. J Biol Chem. 276: 4972-4980.
11. Tang D, Lahti JM, Kidd VJ (2000). Caspase-8 activation and bid cleavage contribute to MCF7 cellular execution in a caspase-3-dependent manner during staurosporine-mediated apoptosis. J Biol Chem. 275: 9303-9307. (Pubitemid 30185152)
12. Vallorosi CJ, Day KC, Zhao X, Rashid MG, Rubin MA, Johnson KR, Wheelock MJ, Day ML (2000). Truncation of the beta-catenin binding domain of E-cadherin precedes epithelial apoptosis during prostate and mammary involution. J Biol Chem. 275: 3328-3334. (Pubitemid 30083035)
13. Wang L, Li Z, Wang C, Yang Y, Sun L, Yao W, Cai X, Wu G, Zhou F, Zha X (2009). E-cadherin decreased human breast cancer cells sensitivity to staurosporine by up-regulating Bcl-2 expression. Arch Biochem Biophys. 481: 116-122.
14. Yang J, Liu X, Bhalla K, Kim CN, Ibrado AM, Cai J, Peng TI, Jones DP, Wang X (1997). Prevention of apoptosis by Bcl-2: release of cytochrome c from mitochondria blocked. Science. 275: 1129-1132. (Pubitemid 27097312)
15. Zhang B, Beeghly-Fadiel A, Long J, Zheng W (2011). Genetic variants associated with breast-cancer risk: comprehensive research synopsis, meta-analysis, and epidemiological evi dence. Lancet Oncol. 12: 477-488.